Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
The U.S. drug giant had initially planned to sell about 540 million shares but increased this to 640 million due to strong demand, a book-runner on the deal stated. Haleon confirmed it will repurchase approximately 60.5 million of its shares from Pfizer for 230 million pounds ($307.4 million).Pfizer Inc. (NYSE:PFE) has divested a $3.3 billion stake in Haleon (NYSE:HLN), reducing its holding in the British consumer healthcare company.
辉瑞股份有限公司（纽交所:PFE）已经将33亿美元的股份在Haleon（纽交所:HLN）中出售，将其持有的英国消费保健公司的股份减少。
What Happened: The transaction occurred on Monday, cutting Pfizer's shareholding from 22.6% to 15%. The shares were sold at 380 pence each, a 3.3% discount to Haleon's last closing price.
事情经过：交易发生在星期一，将辉瑞的参股比例从22.6%降至15%。每股售价为380便士，比Haleon上次收盘价低3.3%。
Haleon, known for products like Sensodyne toothpaste and Panadol painkillers, saw its shares drop 1.2% to 388 pence in Tuesday morning trade. Despite the sale, Pfizer remains Haleon's largest shareholder.
Haleon以Sensodyne牙膏和Panadol止痛药等产品而闻名，周二上午交易时，其股价下跌1.2%至388便士。尽管卖出，辉瑞仍然是Haleon最大的股东。
The U.S. drug giant had initially planned to sell about 540 million shares but increased this to 640 million due to strong demand, a book-runner on the deal stated. Haleon confirmed it will repurchase approximately 60.5 million of its shares from Pfizer for 230 million pounds ($307.4 million).
这家美国药品巨头最初计划出售约54000万股，但由于强劲需求增至64000万股，交易主承销商表示。Haleon确认将从辉瑞手中回购约6050万股，价格为2.3亿英镑（30740万美元）。
Why It Matters: This divestment comes on the heels of Pfizer's recent challenges.
为什么重要：这一出售发生在辉瑞最近面临挑战之际。
On Thursday, Pfizer announced the voluntary withdrawal of its sickle cell disease treatment Oxbryta (voxelotor) from the global market due to severe complications and deaths. This decision also included halting all active clinical trials and expanding access programs for the drug.
上周四，辉瑞宣布自愿将其镰刀形红细胞病治疗药物Oxbryta（体积奥拜卡）从全球市场撤出，因严重并发症和死亡。该决定还包括停止所有临床试验和扩大该药物的使用计划。
Price Action: Pfizer Inc. stock closed at $28.94 on Monday, down 0.52% for the day, and is currently trading at $29.01 in pre-market, reflecting a slight gain of 0.24%. Year-to-date, Pfizer's stock has declined by 2.66%.
股价走势：辉瑞股份有限公司周一收盘价为28.94美元，下跌了0.52%，目前在盘前交易中以29.01美元交易，反映出轻微的增长0.24%。截至目前，辉瑞的股价已下跌了2.66%。
Meanwhile, Haleon PLC – ADR finished at $10.58, down 0.84% on the same day, with a pre-market price up by 0.19%. The stock has performed well this year, rising by 28.55%, according to data from Benzinga Pro.
与此同时，Haleon PLC – ADR在同一天收盘价为10.58美元，下跌了0.84%，盘前价格上涨了0.19%。根据Benzinga Pro的数据显示，该股今年表现不错，涨幅为28.55%。
- Nvidia Stock Could Touch $800 By 2030, BGG Executive Predicts 550% Upside Driven By AI Revolution And Web3 Transition
- 英伟达股票可能在2030年触及800美元，BGG高管预测550%的上升，这是由人工智能革命和Web3过渡推动的。
Image Via Shutterstock
图片来自Shutterstock。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免责声明：本内容部分使用人工智能工具生成，并经Benzinga编辑审核发布。